Targeted Radiopharmaceuticals Summit US

Kongressthemen
The brand-new Targeted Radiopharmaceuticals US Summit (TRP US) is the only industry-led meeting dedicated to the development of next-generation radioligands. The TRP sector has developed dramatically over the previous 18 months, with a wave of new investment in light of Lutathera's extraordinary performance.

Are you part of a pharmaceutical business aiming to have their Theranostic approved?

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Speakers: Sarah Cheal, Assistant Professor, Weill Cornell Medical College, Alan B. Packard, Sr. Research Associate/Associate Professor, Boston Children's Hospital/Harvard Medical School, Stanley Satz, Chairman, Advanced Innovative Partners and more.

https://go.evvnt.com/1065196-2?pid=4832

Frau Erin Thomas